Opinion

Video

Ideal Candidates for Bronchiectasis Surgeries

Panelists discuss how ideal candidates for bronchiectasis surgery have localized disease on CT scan and bronchoscopy, adequate pulmonary function (orced expiratory volume in 1 second > 40%), and whose infections are controlled prior to surgery.

Clinical Brief: Surgical Management of Bronchiectasis

Main Discussion Topics

  • Ideal surgical candidates have localized disease and adequate pulmonary function.
  • Preoperative optimization of infection status is crucial for successful outcomes.
  • Collaboration between pulmonologists and surgeons is essential during patient selection.

Key Points for Physicians

  • Surgical consideration criteria:
    • Forced expiratory volume in 1 second and diffusing capacity of the lung for carbon monoxide values of greater than 40% to minimize morbidity and mortality
    • Disease localized to a segment or lobe on CT imaging
    • Identification of affected area via bronchoscopy
    • Adequate control of active infection before surgery
  • Common indications include:
    • Refractory infections despite optimal medical management
    • Intolerance to long-term antibiotics
    • Aspergillus fungal masses
    • Macrolide-resistant nontuberculous mycobacteria with localized infection
    • Hemoptysis (after initial management with bronchoscopy/embolization)

Notable Insights

Complete resection of affected areas can lead to significant symptom improvement and reduced need for ongoing medications when disease is localized.

Clinical Significance

Surgical management represents an important option for select patients with bronchiectasis with localized disease when medical management has failed to control symptoms or infections.

Related Videos
Christine Funke, MD
5 experts are featured in this series
1 expert in this video
1 expert in this video
Dr Margrit Wiesendanger
4 experts are featured in this series.
5 experts in this video
4 experts are featured in this series.
5 experts in this video
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo